Hook & thesis
PJT Partners is a boutique advisory that specializes in strategic advisory, restructuring and special situations. That specialization matters right now. Stress is rising in private credit for smaller borrowers and in pockets of AI-related lending; when credit cracks, boards and lenders call advisors who know how to navigate restructuring, recapitalizations and contested M&A. PJT is set up to be one of those go-to firms.
Near-term headlines around slowing M&A have pressured the stock, but the market is underpricing the optionality from an uptick in distressed and credit-driven mandates. At a market capitalization roughly in the $3.6B range and an enterprise value of about $3.42B, PJT is trading at ~8.3x EV/EBITDA and ~18.3x P/E - valuations that leave room for a multi-quarter re-rating if deal flow shifts from pure M&A to restructurings and special situations.
What PJT does and why investors should care
PJT provides strategic advisory, shareholder engagement, restructuring and special situations, and private fund advisory and placement services to corporations, sponsors, institutional investors and governments. That breadth matters because advisory revenue is lumpy: when markets are calm, traditional M&A and placement fees dominate; when credit stress appears, restructuring and special situations can become a higher-margin, higher-fee stream.
The market should care for two reasons. First, the company already demonstrated it can produce strong results when activity picks up: Q2 2025 GAAP revenue was $406.9M (up 13% year-over-year) and adjusted EPS beat the Street at $1.54. Second, PJT's balance sheet and cash generation give it optionality to invest in talent and pursue special-situation mandates; free cash flow was reported at roughly $661.8M, and the company shows favorable return metrics: ROE is extremely high at ~63.9% and ROA ~11.36%, indicating a profitable fee business with strong returns on capital.
Support from the numbers
- Market cap: approximately $3.6B; enterprise value: about $3.42B.
- Valuation: ~8.3x EV/EBITDA and ~18.3x P/E, P/S ~1.94, price-to-cash-flow ~5.12. These multiples are reasonable for an advisory with cyclical but high-margin fees.
- Cash flow: free cash flow is sizable at ~$661.8M, implying the firm converts advisory revenue into real cash margins.
- Recent operating evidence: record Q2 2025 revenue of $406.9M (+13% YoY) and adjusted EPS of $1.54 demonstrate earnings leverage when transaction activity is healthy.
- Balance sheet and liquidity: current and quick ratios are both ~1.24, giving the firm enough short-term buffer while it participates in deal work that can take months to monetize.
Why a stressed AI/tech credit environment is a catalyst
Two threads converge here: (1) rising private-credit stress among smaller borrowers (noted industry-wide) means more loans trading below par and a pickup in restructurings; (2) pockets of AI investment have been financed with private credit and sponsor-backed structures that are now being re-priced as rates rose. When lenders and sponsors face underperforming assets, they turn to advisors to restructure debt, run strategic alternatives and manage stakeholder negotiations. PJT's core capabilities are precisely in those areas.
Valuation framing
PJT is not priced like a pure momentum M&A play. The firm currently sits at ~18.3x P/E and 8.3x EV/EBITDA with EV around $3.42B. For a high-ROE advisory business with strong cash generation, those multiples look conservative if transaction mix shifts toward restructuring and special situations, where fees can be both larger and faster to recognition on a per-deal basis. The stock is also trading well below its 52-week high of $195.62 and only modestly above its 52-week low of $127.73, leaving room for mean reversion if high-fee work returns.
| Metric | Value |
|---|---|
| Market cap | $3.6B |
| Enterprise value | $3.42B |
| EV/EBITDA | 8.3x |
| P/E | 18.3x |
| Free cash flow (trailing) | $661.8M |
| ROE | 63.9% |
Catalysts (what could drive the trade)
- Acceleration in restructuring mandates as private credit stress becomes more visible in AI and small-to-mid tech borrowers - these are higher-fee and immediate revenue events for PJT.
- A visible uptick in contested M&A or shareholder engagement activity tied to weak public valuations in the sector - PJT excels at strategic advisory and shareholder engagement.
- Quarterly results that show relative mix shift toward special situations or record backlog/fees-in-the-door, confirming the thesis that deal flow is moving from plain vanilla M&A to restructuring.
- Analyst revisions reversing downgrades if the firm reports sequential strength in advisory mandates tied to credit stress.
Trade plan (actionable)
Trade direction: Long.
Entry price: $141.07.
Target price: $170.00.
Stop loss: $130.00.
Horizon: mid term (45 trading days). I expect this trade to play out over the next 30-45 trading days as the market begins to price in increased restructuring/special-situation fees. If catalysts accelerate sooner, the position can be trimmed; if the thesis stalls but the business shows incremental signs of stabilization, a re-evaluation is warranted.
Rationale for sizing and levels: Entry near $141 is at the current market price and offers a logical risk band to recent support around the low $128-$130 area (52-week low $127.73). The $130 stop preserves capital if M&A weakness deepens without offsetting special-situation mandates. The $170 target implies a re-rating to a more normalized advisory multiple and partial recovery toward mid-2026 levels as market sentiment improves.
Technical backdrop
Momentum indicators are mixed-to-constructive. Price sits above the 10- and 20-day SMAs ($137 and $138.9) but below the 50-day ($156.55), RSI is neutral at ~45, and the MACD histogram shows bullish momentum. Short interest has moderated to a days-to-cover around 3.86 most recently, but short-volume data shows elevated shorting on multiple recent sessions - a sign that a strong positive catalyst could produce a sharp move higher.
Risks and counterarguments
- Macro slowdown and sustained M&A weakness. If higher rates continue to choke deal-making across the board and restructuring activity remains limited, advisory revenue could stay depressed and the stock would likely fall further.
- Competition for restructuring mandates. Larger banks and specialized boutiques will compete aggressively for special-situation work; PJT may not win a material share of new distressed mandates.
- Concentration of deals and lumpy revenue. PJT's fee model is inherently lumpy; one or two lost large mandates in a quarter can materially impact results, which increases earnings volatility.
- Analyst downgrades and sentiment swings. Recent downgrades highlight sensitivity to rate-driven deal flow. Negative revisions can put near-term pressure on the stock even if the medium-term restructuring story plays out.
Counterargument: The market is right to be cautious: if stress is concentrated among smaller borrowers that lack high-fee complex structures, PJT may not capture enough incremental fees to materially move financials. In that scenario, the firm could show only modest upside while multiple compression continues.
What would change my mind
I would downgrade this trade if (a) quarterly disclosures show a continued sequential decline in restructuring and special-situation mandates and no offset from placement or strategic advisory, (b) free cash flow conversion deteriorates materially from current levels, or (c) management signals structural headwinds to winning distressed mandates (e.g., pricing pressure or client concentration issues). Conversely, I would add to the position if PJT reports a visible backlog increase in restructuring work or announces a set of mandates tied to AI-related credit stress.
Conclusion
PJT is a focused advisory franchise that is well-positioned to benefit if credit stress in AI and smaller tech/private-credit borrowers broadens. The stock trades at reasonable multiples given its cash generation and extraordinarily high ROE. This is a mid-term, catalytic trade: buy at $141.07, place a hard stop at $130, and target $170 over the next 45 trading days. The path is not risk-free, but the optionality and valuation look attractive if distressed and special-situation work pick up.
Note: Monitor deal flow, quarterly backlog commentary, and fee-mix changes closely; those are the clearest early signals that the thesis is working.